Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 167 publications
Adropin protects against cardiac remodeling and metabolic dysfunction in a male mouse HFpEF model.
Journal: Clinical science (London, England : 1979)
Published: May 21, 2026
Adropin protects against cardiac remodeling and metabolic dysfunction in a male mouse HFpEF model.
Journal: Clinical science (London, England : 1979)
Published: May 21, 2026
Pulmonary Primary Oxysterol and Bile Acid Synthesis as a Predictor of Outcomes in Pulmonary Arterial Hypertension.
Journal: American journal of respiratory and critical care medicine
Published: April 15, 2026
Endothelial ADAR1 Deficit Induces the NOCT-IRF7 Axis in Pulmonary Hypertension.
Journal: Circulation research
Published: December 04, 2025
Lactate dehydrogenase-induced DNA Topoisomerase 1 is a novel regulator of smooth muscle cell proliferation and remodeling in pulmonary arterial hypertension.
Journal: bioRxiv : the preprint server for biology
Published: November 26, 2025
Deficiency of Smooth Muscle Adar1 Exacerbates Vascular Remodeling and Pulmonary Hypertension.
Journal: Circulation research
Published: October 22, 2025
Deep Learning Predicts Cardiac Output from Seismocardiographic Signals in Heart Failure.
Journal: The American journal of cardiology
Published: September 05, 2025
Astrocytic frataxin deficiency drives neurocognitive impairment in sickle cell mice.
Journal: PNAS nexus
Published: August 24, 2025
Deep learning predicts cardiac output from seismocardiographic signals in heart failure.
Journal: medRxiv : the preprint server for health sciences
Published: August 12, 2025
Bidirectional Crosstalk Between Sleep and Pulmonary Arterial Hypertension.
Journal: bioRxiv : the preprint server for biology
Published: August 08, 2025
Last Updated: 09/26/2026